# Safety Study of P28GST Treatment in Crohn's Disease Patients

> **NCT02281916** · PHASE2 · COMPLETED · sponsor: **University Hospital, Lille** · enrollment: 10 (actual)

## Conditions studied

- Crohn's Ileocolitis

## Interventions

- **DRUG:** P28GST

## Key facts

- **NCT ID:** NCT02281916
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02281916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02281916, "Safety Study of P28GST Treatment in Crohn's Disease Patients". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT02281916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*